Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 22, 2022

SELL
$7.31 - $11.85 $826 - $1,339
-113 Reduced 0.65%
17,336 $168,000
Q1 2022

Apr 26, 2022

SELL
$7.35 - $10.63 $7,813 - $11,299
-1,063 Reduced 5.74%
17,449 $143,000
Q4 2021

Jan 14, 2022

SELL
$4.19 - $9.56 $4,190 - $9,560
-1,000 Reduced 5.13%
18,512 $177,000
Q1 2021

Apr 27, 2021

SELL
$4.52 - $7.8 $6,101 - $10,530
-1,350 Reduced 6.47%
19,512 $103,000
Q4 2020

Jan 29, 2021

BUY
$4.37 - $9.46 $2,263 - $4,900
518 Added 2.55%
20,862 $147,000
Q3 2020

Oct 29, 2020

BUY
$8.56 - $26.93 $51,753 - $162,818
6,046 Added 42.29%
20,344 $184,000
Q2 2020

Jul 28, 2020

BUY
$21.21 - $31.55 $424 - $631
20 Added 0.14%
14,298 $393,000
Q1 2020

May 04, 2020

BUY
$18.43 - $38.04 $42,665 - $88,062
2,315 Added 19.35%
14,278 $314,000
Q4 2019

Jan 29, 2020

BUY
$29.6 - $43.71 $11,573 - $17,090
391 Added 3.38%
11,963 $451,000
Q3 2019

Nov 12, 2019

BUY
$29.87 - $42.22 $345,416 - $488,232
11,564 Added 144550.0%
11,572 $357,000
Q3 2019

Nov 12, 2019

SELL
$29.87 - $42.22 $278,716 - $393,954
-9,331 Reduced 99.91%
8 $357,000
Q2 2019

Aug 06, 2019

BUY
$31.16 - $39.46 $291,003 - $368,516
9,339 New
9,339 $369,000

Others Institutions Holding TCDA

About Tricida, Inc.


  • Ticker TCDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,668,900
  • Market Cap $557K
  • Description
  • Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...
More about TCDA
Track This Portfolio

Track Stratos Wealth Partners, Ltd. Portfolio

Follow Stratos Wealth Partners, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.